Mark Robinson is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as a Senior Executive Therapeutic Specialist at Insmed Incorporated since January 2018. Robinson has been recognized multiple times as a President’s Club Winner from 2019 to 2024 and has contributed to a rare disease launch in the pulmonary-infectious disease sector. Previously, Robinson held positions at Intercept Pharmaceuticals and Boehringer Ingelheim, garnering awards for core values and top sales performance, including a Core Values Award and a Top 10% national TRx volume achievement. Robinson also achieved milestone goal attainments at Vertex Pharmaceuticals and completed management development programs at Boehringer Ingelheim, where a rating of Tier 1 was earned. Robinson holds a Bachelor of Science degree in Marine Biology from the University of North Carolina at Wilmington.
This person is not in the org chart
This person is not in any offices